Australian Study Explores Relative Cost Effectiveness of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
33
Australian Study Explores Relative Cost Effectiveness of Different Treatment Programs: Modelling Suggests Potential Long-term Advantage of Referral to Dedicated Weight Management Program

Silver Spring, MD, Aug. 27, 2018 (GLOBE NEWSWIRE) -- New research suggests that cost savings could be realized when patients receive a referral to a commercial weight management program instead of receiving care from their primary care provider alone, according to a study published in the August issue of Obesity . The University of Sydney study is the first to use a modelling approach to predict the potential population cost effectiveness of referral to a dedicated weight management program for weight management. Based on the outcomes of the simulation, the authors estimate that over a 10-year period, implementation of physician referral to a local Weight Watchers program might help avert as many as 60,500 cases of obesity nationwide and reduce obesity-related healthcare costs by as much as $17 million (Australian dollars).

“Primary care professionals are facing an increasing number of patients with obesity needing treatment,” said Dr. Sharyn Lymer, the study’s lead author and research fellow at the Boden Institute of Obesity Nutrition, Exercise and Eating Disorders at the University of Sydney in Australia. Lymer added that the results of the study suggest another potentially more cost effective treatment opportunity. The study’s authors explain that the obesity epidemic continues to persist in Australia. More than 63 percent of Australians aged 18 years and older had overweight or obesity in 2014 and 2015. The excess cost of direct healthcare for Australians aged 18 years and older who have obesity was reported at $3.8 billion (Australian dollars) in 2015—equivalent to 2.5 percent of the total Australian healthcare cost. To determine the potential cost savings with a referred care approach, researchers used microsimulation—a method of modelling real-life events by simulating the actions of individual units that comprise a system. Researchers modelled the Australian population with eligibility for the intervention for those between the ages of 20 to 64 who had a body mass index (BMI) equal to or higher than 27 kg/m 2 . In the simulation, it was assumed that 17.5 percent of eligible participants would opt to receive a referral from their primary care physician to attend a weekly community meeting of the Weight Watchers program and that 61 percent of those would complete the one-year program. For those receiving standard care, the model assumed the same participation rate but with a 54 percent completion rate.  The standard care approach included receiving weight management advice and monitoring from their general practitioner or primary care physician for an average of ten 20-minute consultations over a year.  Simulations of both interventions were used to predict population health outcomes after one, five and 10 years. The model predicted that referral to a commercial program would lead to a one percent decrease in the prevalence of obesity after one year, while use of the standard care approach would generate a half percent decrease.  Both decreases are predicted to continue over the full 10-year period modelled.  The authors also note that the model predicted that the commercial weight management intervention would perform better on every health and economic outcome examined. The authors note that while simulations predicted that both interventions would reduce the number of adults with obesity, neither approach would allow the country to meet the World Health Organization recommendations for population obesity levels in 2025. Lymer and Michelle Cardel, PhD, MS, RD, FTOS, an assistant professor in the Department of Health Outcomes and Biomedical Informatics at the University of Florida College of Medicine, both agree that greater access to care is needed, including population-level, cost-effective interventions to address obesity. “The use of a simulation model to predict cost-savings for the Weight Watchers-based program as an obesity treatment provides interesting and novel data” said Cardel. “While this is exciting news, simulation models are a simplification of the complex reality that can occur when seeking obesity treatment, and thus possesses inherent limitations. Future study is needed to assess if provider referral to Weight Watchers on a large-scale would result in clinically meaningful weight loss over the long-term.” The development of the microsimulation model used in this study was funded by a National Health and Medical Research Council program grant. Weight Watchers International provided no financial or other support for this study, and the authors declared no research funding or other remuneration from Weight Watchers. Lymer, Deborah Schofield and Stephen Colagiuri have received grants for other research from Novo Nordisk. Nicholas Fuller and Ian Caterson have received research grants from Sanofi, Allergan, Eli Lilly and Novo Nordisk. Caterson was a board member for the SCOUT trial, is on the EXSCEL Operations Committee, and has received payment for lectures from iNova Pharmaceuticals, Pfizer Australia and Servier Laboratories (Australia). Michelle Cunich and Crystal Man Ying Lee declared no conflict of interest.

#   #   #

 

This press release can be published in full or in part with attribution to The Obesity Society.

The Obesity Society (TOS) is the leading organization of scientists and health professionals devoted to understanding and reversing the epidemic of obesity and its adverse health, economic and societal effects.  Combining the perspective of physicians and other clinicians, scientists, policymakers and patients, TOS promotes innovative research, education, and evidence-based clinical care to improve the health and well-being of all people with obesity. For more information, visit www.obesity.org and connect with us on Facebook , Twitter and LinkedIn .

Kristin D. Collins The Obesity Society 240-485-1950 kcollins@obesity.org

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 5

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 6

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Portable Battery Charger Set to Transform EV Charging

Updated Category News Views 207

Introduction to the New Battery Charger for Electric Vehicles In a world where electric vehicles (EVs) are becoming more prevalent, the quest for convenience and reliability in charging options has led to the creation of an exciting new product. An inventive mind has developed a portable battery charger designed specifically for electric cars, addressing the significant...

Continue Reading
How to Calculate Rental Property Returns in Calgary

Updated Category Real Estate Views 549

The growth of the future value is not sufficient to invest in rental property, particularly in a market place such as Calgary where the economic cycles and population dynamics may affect the results. By computing the returns on the rental property, investors are able to know whether a property will be able to produce sustainable returns as they accumulate long te

Continue Reading
Understanding BioCardia's Upcoming Earnings Announcement

Updated Category News Views 196

BioCardia's Anticipated Earnings Report BioCardia (NASDAQ: BCDA) is gearing up for its next quarterly earnings announcement. Investors are keen to hear the results as they look to gain insights into the company's performance and future expectations. Expected Earnings Per Share Current estimates suggest that BioCardia will report an earnings per share (EPS) of...

Continue Reading
A New Look at Trump's First Month and Children's Concerns

Updated Category News Views 501

President Trump's Impact During His Initial Month As President Trump's new term unfolds, impactful events are shaping his administration's direction. The first month has been marked by significant developments, highlighted by the Senate's confirmation of Kash Patel as the Director of the FBI. This move is seen as a pivotal moment, emphasizing a commitment to addressing...

Continue Reading
Eramet Faces Revenue Decrease Amid Logistics Hurdles

Updated Category News Views 286

Eramet Revenue Decline in Q3 2025 Eramet has reported a decline in its adjusted turnover for the third quarter of 2025, which totaled €720 million. This marks a 10% decrease compared to the same quarter in 2024. The decrease primarily stems from significant external factors affecting sales and market conditions. Safety and CSR Achievements Despite facing a challenging...

Continue Reading